Selective (SIGI) Q4 2025 Earnings Transcript

Selective Insurance Group reported strong 2025 results, with ROE of 14.4%, book value per share up 18%, and the full-year combined ratio improving to 97.2% from 103% in 2024. The company returned $182 million to shareholders and still has $170 million remaining on its buyback authorization, while 2026 guidance calls for a 96.5%-97.5% GAAP combined ratio and $465 million of after-tax net investment income, up 10%. Offsetting the positives are ongoing reserve volatility, including $190 million of commercial auto reserve strengthening and continued New Jersey-driven personal auto pressure, plus a planned 0.5-point expense ratio increase from technology investments.

Analysis

Selective is in the awkward but usually investable phase where underwriting repair and capital return can coexist. The market will likely underappreciate that the near-term “noise” from reserve strengthening is actually a forcing function for margin reset: once recent accident-year adequacy is rebuilt, the company can re-rate the book faster than peers still stretching for volume. The bigger second-order winner is not just SIGI’s earnings power, but its ability to keep repurchasing stock while maintaining a conservative balance sheet, which compounds book value per share faster than peers that are using capital to defend top-line share.

The main bear case is geographic concentration of litigation inflation, not broad industry pricing. New Jersey is the pressure valve that can keep masking underlying improvement for multiple quarters, and the risk is that pricing discipline lags legal severity long enough that reported combined ratios stay volatile even as management is right on the underlying trend. That matters because insurance stocks trade on perceived reserve credibility; if investors start discounting the “best estimate” process, the multiple can compress even with decent ROE.

The contrarian setup is that consensus may be overfocusing on the expense-ratio step-up and underweighting the earnings mix shift from reserve-normalization plus stronger investment income. If rates stay anywhere near current levels, the investment book is a persistent tailwind, but the real upside surprise is that technology spend can create a future expense inflection if management is right on labor productivity. This is a 6-12 month thesis, not a one-week trade: the catalyst path is cleaner reserve data, another quarter of strong NII, and evidence that retention can stay stable while unprofitable business is trimmed.

Relative-value, SIGI looks better as a quality compounder than a momentum name. The key is that the stock should benefit if the market rotates back toward defensive financials with visible capital return and less credit sensitivity, while pure growth insurers get punished for higher loss trend assumptions and softer rate optics.

Key Decisions for Investors

• Long SIGI on a 6-12 month horizon; target a re-rating as reserve credibility stabilizes and buybacks continue. Best risk/reward if entered on any post-earnings pullback tied to New Jersey noise.
• Pair trade: long SIGI / short a more rate-sensitive commercial P&C peer with weaker reserve history over the next 1-2 quarters. The thesis is SIGI’s capital return and NII durability offset near-term underwriting volatility.
• Sell downside via a SIGI put spread 2-3 quarters out if liquidity allows; volatility should remain elevated on reserve headlines, but the fundamental downside looks limited by book value growth and ongoing repurchases.
• Avoid chasing the stock immediately after quarters with reserve charges; wait for the next clean underlying combined ratio print as the likely catalyst for multiple expansion.
• If SIGI trades to a premium multiple above peers before NJ trends improve, trim or hedge with a short against a broader P&C basket to express the view that the story is still execution-dependent.